100 related articles for article (PubMed ID: 11124590)
1. Lipophilic antioxidants and iron status in ESRD patients on hemodialysis.
Lim PS; Chan EC; Lu TC; Yu YL; Kuo SY; Wang TH; Wei YH
Nephron; 2000 Dec; 86(4):428-35. PubMed ID: 11124590
[TBL] [Abstract][Full Text] [Related]
2. Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis.
Lim PS; Wang NP; Lu TC; Wang TH; Hsu WM; Chan EC; Hung WR; Yang CC; Kuo IF; Wei YH
Nephron; 2001 Jun; 88(2):127-33. PubMed ID: 11399914
[TBL] [Abstract][Full Text] [Related]
3. Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters: influence of serum ferritin levels.
Chen WT; Lin YF; Yu FC; Kao WY; Huang WH; Yan HC
Am J Kidney Dis; 2003 Jul; 42(1):158-66. PubMed ID: 12830468
[TBL] [Abstract][Full Text] [Related]
4. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
Prakash M; Upadhya S; Prabhu R
Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
[TBL] [Abstract][Full Text] [Related]
5. Pathological role of aminolevulinate in uremic patients.
Hasuike Y; Nonoguchi H; Tokuyama M; Hata R; Kitamura R; Hori K; Nanami M; Otaki Y; Kuragano T; Nakanishi T
Ther Apher Dial; 2011 Feb; 15(1):28-33. PubMed ID: 21272249
[TBL] [Abstract][Full Text] [Related]
6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy.
Lim PS; Wei YH; Yu YL; Kho B
Nephrol Dial Transplant; 1999 Nov; 14(11):2680-7. PubMed ID: 10534512
[TBL] [Abstract][Full Text] [Related]
8. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
9. Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients.
Lien CT; Lin KC; Tsai YF; Yu LK; Huang LH; Chen CA
Clin Exp Nephrol; 2015 Oct; 19(5):947-52. PubMed ID: 25536924
[TBL] [Abstract][Full Text] [Related]
10. HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients.
Valenti L; Valenti G; Como G; Burdick L; Santorelli G; Dongiovanni P; Rametta R; Bamonti F; Novembrino C; Fracanzani AL; Messa PG; Fargion S
Am J Nephrol; 2007; 27(1):101-7. PubMed ID: 17299255
[TBL] [Abstract][Full Text] [Related]
11. [Serum ferritin in renal insufficiency, hemodialysis and kidney transplantation].
Hofmann V; Descoeudres C; Montandon A; Galeazzi RL; Straub PW
Schweiz Med Wochenschr; 1978 Nov; 108(47):1835-8. PubMed ID: 362527
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
[TBL] [Abstract][Full Text] [Related]
13. [Iron balance in hemodialysis in chronic uremia].
Kokot F; Warmuz A
Z Urol Nephrol; 1988 Apr; 81(4):263-8. PubMed ID: 3400353
[TBL] [Abstract][Full Text] [Related]
14. Relation of antioxidants and acute-phase reactants in patients receiving hemodialysis.
Samadian F; Lessan-Pezeshki M; Mahdavi-Mazdeh M; Kadkhodaie M; Seifi S; Ahmadi F
Iran J Kidney Dis; 2007 Jul; 1(1):38-42. PubMed ID: 19357443
[TBL] [Abstract][Full Text] [Related]
15. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.
Ferretti G; Bacchetti T; Masciangelo S; Pallotta G
Clin Biochem; 2008 Apr; 41(6):381-6. PubMed ID: 18194672
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
20. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
